PLOS Computational Biology marks 20 years with a retrospective on genomics submissions
Two decades after PLOS Computational Biology opened its pages to computationally driven biology, the journal is using its own archive to ask a simple but revealing question: how has genomics research changed inside this venue over time? In a 20th anniversary commentary, the Editor for the Journal Section of Genomics, Epigenomics, & Proteomics reviewed all submitted research papers in that section since 2017 and framed the exercise as a data-driven reflection on the field’s recent trajectory.
The choice of 2017 is not arbitrary. Editorial Manager records shaped the window of analysis, and the same span also overlaps with the editor’s own work in the area. That creates a practical retrospective with an important caveat: it is not a complete 20-year history of the journal, nor does it pretend to be. Instead, it offers a focused view of a period when genomics matured further as a computational discipline, with methods, datasets, and biological questions becoming more intertwined than ever.
The commentary is less about announcing a single experimental result than about charting scientific movement. That distinction matters because the value of a journal-level review lies in patterns that are easy to miss inside any one paper: the kinds of submissions researchers are making, the topics they return to repeatedly, and the ways genomics continues to intersect with epigenomics and proteomics. A section that receives submissions across these domains becomes a proxy for where computational biology is being pushed most actively.
One sentence captures the whole exercise: a journal archive can function as a scientific barometer.
A narrow time window can still reveal broad movement in the field
A retrospective built from submission records carries an inherent limitation. Editorial systems preserve a slice of activity, not the full ecological record of a discipline, and the commentary is explicit about that boundary. The analysis begins in 2017 because that is where the accessible records begin, not because nothing of significance existed before then. Even so, the selected period is long enough to observe how genomics research has been accumulating, diversifying, and repeatedly testing its own methodological assumptions.
In practice, a data-driven editorial review of submissions can illuminate the kinds of questions that dominate a section over time. Genomics is not a static topic. It is a moving target shaped by sequencing throughput, computational methods, reference resources, and the growing need to interpret large-scale biological data in a rigorous way. When those forces converge inside a journal, the submission stream becomes a record of scientific appetite as much as scientific output.
The section title itself matters. Genomics, epigenomics, and proteomics are related but not interchangeable, and their coexistence within one editorial domain reflects the way modern biology has outgrown single-layer analysis. DNA sequence alone rarely answers the full biological question. Chromatin state, regulatory architecture, and protein-level readouts often determine whether a genomic signal is meaningful, actionable, or merely descriptive. That layered view is central to computational biology, where integrative analysis is often the only way to move from data accumulation to biological interpretation.
Editorial records as a lens on computational genomics
The commentary’s framing also points to a broader truth about scientific publishing: editorial records are not just administrative artifacts. They can be repurposed as evidence of how a field is evolving in real time. Submission histories can reveal whether a journal is attracting more mechanistic studies, more methods development, or more integrative analyses that bridge multiple omics layers. They can also show whether a field is becoming more dependent on computation as data volumes and biological complexity rise together.
In genomics, that shift has been especially pronounced. High-dimensional biological data demand careful statistical modeling, reproducible workflows, and interpretive frameworks that do not overstate what the data can prove. The journal section under review sits directly in that tension. It receives work from a field where the pace of technical change is fast, but the standards for biological credibility remain demanding. A retrospective on submitted papers is therefore not just an editorial exercise; it is an index of how researchers are trying to meet those standards.
For readers in computational biology, the appeal of such a review is straightforward. It can help distinguish transient methodological fashions from durable scientific priorities. It can also remind the community that journal sections are shaped by the people who submit to them, review for them, and edit them over time. A section focused on genomics, epigenomics, and proteomics is inevitably influenced by the growth of multi-omic science, by the need for scalable analysis, and by the increasing expectation that computational work should connect directly to biological meaning.
One practical consequence follows from that reality: journal archives can show where the field is heading before the broader literature fully settles the question.
What this commentary can and cannot claim
Because the available abstract gives no specific counts, categories, or effect sizes, the central contribution of the commentary is conceptual rather than numerical. It announces a retrospective review of submitted papers since 2017 and positions that review as a reflection on the evolution of genomics research within PLOS Computational Biology. The analysis is explicitly bounded by the editorial records available to the journal, and it stops short of claiming to represent the publication’s entire 20-year history.
That restraint is scientifically appropriate. Journal-based retrospectives are most credible when they clearly define their sources, their time frame, and their blind spots. A review that stretches beyond its record base would risk saying more than the archive can support. Here, the boundary is part of the message. The commentary is not trying to rewrite the journal’s full legacy. It is using a well-defined slice of that legacy to show how genomics, in the setting of computational biology, has continued to expand in scope and complexity.
For the field, the implication is quiet but concrete. As genomics becomes more integrated with epigenomic and proteomic analysis, the questions reaching computational journals are likely to grow even more layered, not less. The commentary sets that expectation without overstating it, and it does so from the vantage point of a section editor who has watched the submissions arrive over a meaningful stretch of time. The next phase of the field will depend on whether those submissions continue to pair scale with interpretability, and whether computational methods can keep pace with the biological systems they aim to explain.